Literature DB >> 4163129

Lymphocyte stimulation and chronic liver disease.

H Tobias, A P Safran, F Schaffner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163129     DOI: 10.1016/s0140-6736(67)91830-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

Authors:  K Thestrup-Pedersen; K Ladefoged; P Andersen
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

Review 2.  Chronic hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

3.  In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis.

Authors:  M R Berenyi; B Straus; D Cruz
Journal:  Am J Dig Dis       Date:  1974-03

4.  Cell-mediated immune reactivity in liver disease.

Authors:  P A Bacon; H Berry; R Bown
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

5.  Leucocyte migration inhibition in liver disease.

Authors:  C Vergani; T Oldoni; N Dioguardi
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

6.  [Differential reaction of lymphocytes to phytohemagglutinin (PHA) in liver diseases].

Authors:  R Rössler; K Havemann; W Dölle
Journal:  Klin Wochenschr       Date:  1969-08-01

Review 7.  [Immunologic phenomena in liver diseases: significance of mitochondrial antibodies].

Authors:  P A Berg; D Doniach; I M Roitt
Journal:  Klin Wochenschr       Date:  1969-12-15

8.  Leucocyte migration in chronic hepatitis.

Authors:  C G Vergani; P R Crocchiolo; E F Redaelli
Journal:  Br Med J       Date:  1972-04-29

9.  [Autoimmune diseases].

Authors:  H Begemann
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1970

10.  Chromosomal aberrations in infective hepatitis.

Authors:  N Matsaniotis; K Kiossoglou; F Maounis; D Anagnostakis
Journal:  J Clin Pathol       Date:  1970-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.